Cannara Biotech Inc. (LOVE.V)

CAD 0.68

(0.0%)

Operating Income Summary of Cannara Biotech Inc.

  • Cannara Biotech Inc.'s latest annual operating income in 2023 was 11.88 Million CAD , up 223.73% from previous year.
  • Cannara Biotech Inc.'s latest quarterly operating income in 2024 Q3 was -4.83 Million CAD , up 281.37% from previous quarter.
  • Cannara Biotech Inc. reported an annual operating income of 3.67 Million CAD in 2022, up 1806.65% from previous year.
  • Cannara Biotech Inc. reported an annual operating income of 192.59 Thousand CAD in 2021, up 101.61% from previous year.
  • Cannara Biotech Inc. reported a quarterly operating income of 3.43 Million CAD for 2024 Q1, down -41.03% from previous quarter.
  • Cannara Biotech Inc. reported a quarterly operating income of -4.83 Million CAD for 2024 Q3, up 281.37% from previous quarter.

Annual Operating Income Chart of Cannara Biotech Inc. (2023 - 2018)

Historical Annual Operating Income of Cannara Biotech Inc. (2023 - 2018)

Year Operating Income Operating Income Growth
2023 11.88 Million CAD 223.73%
2022 3.67 Million CAD 1806.65%
2021 192.59 Thousand CAD 101.61%
2020 -11.92 Million CAD -16.69%
2019 -10.22 Million CAD -462.6%
2018 -1.81 Million CAD 0.0%

Peer Operating Income Comparison of Cannara Biotech Inc.

Name Operating Income Operating Income Difference
Aequus Pharmaceuticals Inc. -2.82 Million CAD 521.51%
CanadaBis Capital Inc. 4.67 Million CAD -154.182%
Decibel Cannabis Company Inc. 1.41 Million CAD -741.912%
Delivra Health Brands Inc. -710 Thousand CAD 1774.337%
Entourage Health Corp. -21.37 Million CAD 155.608%
Lifeist Wellness Inc. -12.24 Million CAD 197.043%
Medicure Inc. -854 Thousand CAD 1492.013%
PharmaCielo Ltd. -9.7 Million CAD 222.543%
Rubicon Organics Inc. -1.08 Million CAD 1197.222%
BioSyent Inc. 7.47 Million CAD -59.116%
Voyageur Pharmaceuticals Ltd. -1.22 Million CAD 1073.649%